{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:36:26Z","timestamp":1790854586831,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1124\/mol.64.6.1419","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T00:31:43Z","timestamp":1069893103000},"page":"1419-1427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Soluble Guanylyl Cyclase Activator YC-1 Inhibits Human Neutrophil Functions through a cGMP-Independent but cAMP-Dependent Pathway"],"prefix":"10.1016","volume":"64","author":[{"given":"Tsong-Long","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Wen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hui","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Ming","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha Ju-San","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.64.6.1419_bib1","doi-asserted-by":"crossref","unstructured":"Armstrong R (2001) The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int Immunopharmacol 1: 1501-1512.","DOI":"10.1016\/S1567-5769(01)00094-7"},{"key":"10.1124\/mol.64.6.1419_bib2","doi-asserted-by":"crossref","unstructured":"Borregaard N (1988) The human neutrophil. Function and dysfunction. Eur J Haematol 41: 401-413.","DOI":"10.1111\/j.1600-0609.1988.tb00219.x"},{"key":"10.1124\/mol.64.6.1419_bib3","doi-asserted-by":"crossref","unstructured":"Browning DD, Windes ND, and Ye RD (1999) Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J Biol Chem 274: 537-542.","DOI":"10.1074\/jbc.274.1.537"},{"key":"10.1124\/mol.64.6.1419_bib4","doi-asserted-by":"crossref","unstructured":"Brunetti M, Mascetra N, Manarini S, Martelli N, Cerletti C, Musiani P, Aiello FB, and Evangelista V (2002) Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis. Biochem Biophys Res Commun 297: 498-501.","DOI":"10.1016\/S0006-291X(02)02246-5"},{"key":"10.1124\/mol.64.6.1419_bib5","unstructured":"Coffey RG (1992) Effects of cyclic nucleotides on granulocytes. Immunol Ser 57: 301-338."},{"key":"10.1124\/mol.64.6.1419_bib6","doi-asserted-by":"crossref","unstructured":"Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, Freeman BA, and O\u2019Donnell VB (2002) Nitrolinoleate inhibits superoxide generation, degranulation and integrin expression by human neutrophils: novel anti-inflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91: 375-381.","DOI":"10.1161\/01.RES.0000032114.68919.EF"},{"key":"10.1124\/mol.64.6.1419_bib7","doi-asserted-by":"crossref","unstructured":"El Bekay R, Alvarez M, Carballo M, Martin-Nieto J, Monteseirin J, Pintado E, Bedoya FJ, and Sobrino F (2002) Activation of phagocytic cell NADPH oxidase by norfloxacin: a potential mechanism to explain its bactericidal action. J Leukoc Biol 71: 255-261.","DOI":"10.1189\/jlb.71.2.255"},{"key":"10.1124\/mol.64.6.1419_bib8","doi-asserted-by":"crossref","unstructured":"Ervens J, Schultz G, and Seifert R (1991) Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N 2,2\u2032-O-dibutyryl guanosine 3\u2032:5\u2032-cyclic monophosphate. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 343: 370-376.","DOI":"10.1007\/BF00179041"},{"key":"10.1124\/mol.64.6.1419_bib9","doi-asserted-by":"crossref","unstructured":"Ferrero R and Torres M (2001) Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism. Neuropharmacology 41: 895-906.","DOI":"10.1016\/S0028-3908(01)00131-9"},{"key":"10.1124\/mol.64.6.1419_bib10","doi-asserted-by":"crossref","unstructured":"Friebe A, Mullershausen F, Smolenski A, Walter U, Schultz G, and Koesling D (1998) YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol 54: 962-967.","DOI":"10.1124\/mol.54.6.962"},{"key":"10.1124\/mol.64.6.1419_bib11","doi-asserted-by":"crossref","unstructured":"Friebe A, Schultz G, and Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO (Eur Mol Biol Organ) J 15: 6863-6868.","DOI":"10.1002\/j.1460-2075.1996.tb01078.x"},{"key":"10.1124\/mol.64.6.1419_bib12","doi-asserted-by":"crossref","unstructured":"Galle J, Zabel U, H\u00fcbner U, Hatzelmann A, Wagner B, Wanner C, and Schmidt HHHW (1999) Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol 127: 195-203.","DOI":"10.1038\/sj.bjp.0702495"},{"key":"10.1124\/mol.64.6.1419_bib13","doi-asserted-by":"crossref","unstructured":"Heyworth PG, Shrimpton CF, and Segal AW (1989) Localization of the 47 kDa phosphoprotein involved in the respiratory-burst NADPH oxidase of phagocytic cells. Biochem J 260: 243-248.","DOI":"10.1042\/bj2600243"},{"key":"10.1124\/mol.64.6.1419_bib14","doi-asserted-by":"crossref","unstructured":"Hobbs AJ (2002) Soluble guanylate cyclase: an old therapeutic target re-visited. Br J Pharmacol 136: 637-640.","DOI":"10.1038\/sj.bjp.0704779"},{"key":"10.1124\/mol.64.6.1419_bib15","doi-asserted-by":"crossref","unstructured":"Hwang TL, Wu CC, and Teng CM (1999) YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea. Br J Pharmacol 128: 577-584.","DOI":"10.1038\/sj.bjp.0702830"},{"key":"10.1124\/mol.64.6.1419_bib16","doi-asserted-by":"crossref","unstructured":"Ko FN, Wu CC, Kuo SC, Lee FY, and Teng CM (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84: 4226-4233.","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226"},{"key":"10.1124\/mol.64.6.1419_bib17","doi-asserted-by":"crossref","unstructured":"Lad PM, Glovsky MM, Richards JH, Smiley PA, and Backstrom B (1985) Regulation of human neutrophil guanylate cyclase by metal ions, free radicals and the muscarinic cholinergic receptor. Mol Immunol 22: 731-739.","DOI":"10.1016\/0161-5890(85)90138-5"},{"key":"10.1124\/mol.64.6.1419_bib18","doi-asserted-by":"crossref","unstructured":"Miotla JM, Teixeira MM, and Hellewell PG (1998) Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am J Respir Cell Mol Biol 18: 411-420.","DOI":"10.1165\/ajrcmb.18.3.2913"},{"key":"10.1124\/mol.64.6.1419_bib19","doi-asserted-by":"crossref","unstructured":"Moncada S, Palmer RMJ, and Higgs EA (1991) Nitric oxide-physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142.","DOI":"10.1016\/S0031-6997(25)06663-3"},{"key":"10.1124\/mol.64.6.1419_bib20","doi-asserted-by":"crossref","unstructured":"Morikawa M, Inoue M, Tokumaru S, and Kogo H (1995) Enhancing and inhibitory effects of nitric oxide on superoxide anion generation in human polymorphonuclear leukocytes. Br J Pharmacol 115: 1302-1306.","DOI":"10.1111\/j.1476-5381.1995.tb15040.x"},{"key":"10.1124\/mol.64.6.1419_bib21","doi-asserted-by":"crossref","unstructured":"M\u00fclsch A, Bauersachs J, Sch\u00e4fer A, Stasch JP, Kast R, and Busse R (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120: 681-689.","DOI":"10.1038\/sj.bjp.0700982"},{"key":"10.1124\/mol.64.6.1419_bib22","doi-asserted-by":"crossref","unstructured":"Osinski MT, Rauch BH, and Schr\u00f6r K (2001) Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A. Mol Pharmacol 59: 1044-1050.","DOI":"10.1124\/mol.59.5.1044"},{"key":"10.1124\/mol.64.6.1419_bib23","doi-asserted-by":"crossref","unstructured":"Pryzwansky KB, Wyatt TA, Nichols H, and Lincoln TM (1990) Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. Blood 76: 612-618.","DOI":"10.1182\/blood.V76.3.612.bloodjournal763612"},{"key":"10.1124\/mol.64.6.1419_bib24","doi-asserted-by":"crossref","unstructured":"Rothermund L, Friebe A, Paul M, Koesling D, and Kreutz R (2000) Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol 30: 205-208.","DOI":"10.1038\/sj.bjp.0703320"},{"key":"10.1124\/mol.64.6.1419_bib25","doi-asserted-by":"crossref","unstructured":"Schudt C, Winder S, Forderkunz S, Hatzelmann A, and Ullrich V (1991) Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 344: 682-690.","DOI":"10.1007\/BF00174752"},{"key":"10.1124\/mol.64.6.1419_bib26","doi-asserted-by":"crossref","unstructured":"Sedgwick JB, Berube ML, and Zurier RB (1985) Stimulus-dependent inhibition of superoxide generation by prostaglandins. Clin Immunol Immunopathol 34: 205-215.","DOI":"10.1016\/0090-1229(85)90025-X"},{"key":"10.1124\/mol.64.6.1419_bib27","doi-asserted-by":"crossref","unstructured":"Stone JR and Marletta MA (1998) Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 5: 255-261.","DOI":"10.1016\/S1074-5521(98)90618-4"},{"key":"10.1124\/mol.64.6.1419_bib28","doi-asserted-by":"crossref","unstructured":"Tan AS and Berridge MV (2000) Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods 238: 59-68.","DOI":"10.1016\/S0022-1759(00)00156-3"},{"key":"10.1124\/mol.64.6.1419_bib29","doi-asserted-by":"crossref","unstructured":"Tintinger GR, Theron AJ, Anderson R, and Ker JA (2001) The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium. Biochem Pharmacol 61: 1319-1328.","DOI":"10.1016\/S0006-2952(01)00588-3"},{"key":"10.1124\/mol.64.6.1419_bib30","doi-asserted-by":"crossref","unstructured":"Tulis DA, Durante W, Peyton KJ, Chapman GB, Evans AJ, and Schafer AI (2000) YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochem Biophys Res Commun 279: 646-652.","DOI":"10.1006\/bbrc.2000.3942"},{"key":"10.1124\/mol.64.6.1419_bib31","doi-asserted-by":"crossref","unstructured":"Underwood DC, Bochnowicz S, Osborn RR, Kotzer CJ, Luttmann MA, Hay DW, Gorycki PD, Christensen SB, and Torphy TJ (1998) Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. J Pharmacol Exp Ther 287: 988-995.","DOI":"10.1016\/S0022-3565(24)37892-9"},{"key":"10.1124\/mol.64.6.1419_bib32","doi-asserted-by":"crossref","unstructured":"Wang JP, Chang LC, Raung SL, Hsu MF, Huang LJ, and Kuo SC (2002) Inhibition of superoxide anion generation by YC-1 in rat neutrophils through cyclic GMP-dependent and -independent mechanisms. Biochem Pharmacol 63: 577-585.","DOI":"10.1016\/S0006-2952(01)00882-6"},{"key":"10.1124\/mol.64.6.1419_bib33","doi-asserted-by":"crossref","unstructured":"Wegener JW, Gath I, Forstermann U, and Nawrath H (1997) Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br J Pharmacol 122: 1523-1529.","DOI":"10.1038\/sj.bjp.0701542"},{"key":"10.1124\/mol.64.6.1419_bib34","doi-asserted-by":"crossref","unstructured":"Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, Strobel H, and Wiemer G (1999) Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol 128: 1316-1322.","DOI":"10.1038\/sj.bjp.0702921"},{"key":"10.1124\/mol.64.6.1419_bib35","doi-asserted-by":"crossref","unstructured":"Wu CC, Ko FN, Kuo SC, Lee FY, and Teng CM (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116: 1973-1978.","DOI":"10.1111\/j.1476-5381.1995.tb16400.x"},{"key":"10.1124\/mol.64.6.1419_bib36","doi-asserted-by":"crossref","unstructured":"Wu CC, Ko FN, and Teng CM (1997) Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem Biophys Res Commun 231: 412-416.","DOI":"10.1006\/bbrc.1996.5998"},{"key":"10.1124\/mol.64.6.1419_bib37","doi-asserted-by":"crossref","unstructured":"Yoshina S and Kuo SC (1978) Studies on heterocyclic compounds. XXXV. Synthesis of flu[3,3-C]pyrazole derivatives. (2) Electrophilic substitution of 1,3-diphenylfuro[3,2-C]pyrazole. Yakugaku Zasshi 98: 204.","DOI":"10.1248\/yakushi1947.98.2_204"},{"key":"10.1124\/mol.64.6.1419_bib38","doi-asserted-by":"crossref","unstructured":"Yu SM, Cheng ZJ, Guh JH, Lee FY, and Kuo SC (1995) Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells. Biochem J 306: 787-792.","DOI":"10.1042\/bj3060787"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24019205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.64.6.1419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:34:09Z","timestamp":1739957649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24019205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0026895X24019205"],"URL":"https:\/\/doi.org\/10.1124\/mol.64.6.1419","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble Guanylyl Cyclase Activator YC-1 Inhibits Human Neutrophil Functions through a cGMP-Independent but cAMP-Dependent Pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.64.6.1419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}